Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : YEEHAW CANDIDATES -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (7515)	4/27/2005 1:17:54 PM
From: rrufff	Read Replies (1) \| Respond to of 23958

Hi Sergio, You might want to take a look at IMX, which has gotten clobbered. They are aligned with CTE in the stent business. Their business goes far beyond though. 2 PR's in the past 2 days may have gotten it off the lows and formed a bottom. Anyone interested should look at the PR's, at least to get a sense of their business, e.g. explosive detection, semiconductor fabrication, prostate radiation seeds, stents, etc. Relatively low float, thin and can move either way very quickly.

To: Sergio H who wrote (7515)	5/4/2005 1:24:10 PM
From: ACAN	Read Replies (2) \| Respond to of 23958

Sergio; CTE news out today re entering the retail market CardioTech to Launch Media Campaign for Sale of AloeGlow Facial Masks 5/4/05 WILMINGTON, Mass., May 4, 2005 /PRNewswire-FirstCall via COMTEX/ -- DermaPhylyx Inc., a division of CardioTech International, Inc. (Amex: CTE), is pleased to announce its association with WBUY Television in the production of direct response commercials for its anti-wrinkle hydrating masque, AloeGlow(TM). WBUY TV is a national multimedia and television production company specializing in direct response television commercials and internet shopping. WBUY features products from a variety of consumer sectors, including health & beauty items, electronics, women's apparel and accessories, kitchen items and children's products. AloeGlow(TM) is a proven, innovative skin care product that provides cleaner, healthier skin in as little as 30 minutes. The masque is made of hydrogel, which has been used for many years in the medical industry to assist in the healing of damaged skin which results from maladies such as diabetic ulcers, and venous stasis ulcers. The masque is then infused with purified aloe, which is one of nature's best moisturizers. AloeGlow(TM) is DermaPhylyx's first cosmetic skin-care product which addresses an enormous domestic and global market which is expanding due to the aging of the population. Moreover, AloeGlow(TM) leverages DermaPhylyx's current manufacturing expertise with hydrogel, which is the basis of its HydroMed(TM) wound dressing for diabetic ulcers. Now, DermaPhylyx and WBUY are bringing the power of this science directly to the American public through WBUY's successful Direct Response Commercial (DRC) business model. "We're very pleased to be working with WBUY TV," commented Dr. Michael Szycher, CEO of DermaPhylyx's parent company, CardioTech International Inc. "WBUY has had great success with their direct response commercials with a number of successful brands, and we think AloeGlow(TM) should be equally successful." The AloeGlow(TM) direct response commercial will air on nationally broadcast cable channels such as Lifetime, Oxygen, and Biography, and air over 5000 times this Spring and Summer, beginning in late April and running through August. The commercials will run at various times during the critical daylight and prime-time hours, and will air in practically all of the United States' most populated media markets including, but not limited to, major skin-care markets such as Miami/Ft. Lauderdale, Dallas/Ft. Worth, Los Angeles and the New York City metropolitan markets. AloeGlow(TM) is designed for women and men from 35-75 years of age who are looking to naturally reduce wrinkles without the expense or side effects associated with more invasive anti-wrinkle therapies. It temporarily reduces facial wrinkles and lines of expression with no known side effects or contra- indications. Allan